2 Market-Beating Growth Stocks That Are Just Getting Started
Sometimes, even a market downturn isn't enough to sink shares of companies firing on all cylinders. That's been the case with Novo Nordisk (NYSE: NVO) and Visa (NYSE: V). These industry leaders have outperformed the market over the trailing-12-month period. Novo Nordisk and Visa have both been around for a while and generally produced excellent returns.
Yet, both companies have miles of growth left ahead, making them exceptional stocks to buy today. Let's dig in.
Novo Nordisk is a longtime leading pharmaceutical company that consistently generates growing revenue and earnings. In 2022, the drugmaker's net sales increased by 26% year over year to about 177 billion Danish kroner ($25.5 billion), although in fairness, currency exchange rate fluctuations worked in the company's favor.
Source Fool.com
